| 【Company Research】Jiumaojiu (9922 HK) – Slightly more cautious after a bumpy Jul-Aug |
| 【Fixed Income Research】ZHLGHD - 1H21 Result in line with expectation |
| 【Company Research】Xiaomi (1810 HK) – 2Q21 beat on strong ads and margin; Maintain BUY |
| 【Company Research】AK Medical (1789 HK) – Results of volume-based procurement to come out in mid-September |
| 【Company Research】Ascentage Pharma Group (6855 HK) – Breakthrough in collaboration deals |
| 【Company Research】Kuaishou (1024 HK) – Cautious on 2H21E momentum |
| 【Company Research】PA Good Doctor (1833 HK) – Increasing expenditures to support strategic expansion |
| 【Company Research】Ming Yuan Cloud (909 HK) – Benefiting from property sector digitalization |
| 【公司研究】拼多多(PDD US) – 2Q21业绩亮眼,利润大超预期 |
| 【Company Research】Ever Sunshine (1995 HK) – 1H21 beat to boost confidence in next 5-year plan; Reiterate Top Pick |